Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll New drug sugammadex: a selective relaxant binding agent Welliver MAANA J 2006[Oct]; 74 (5): 357-63Cyclodextrins are molecules with a hollow, truncated cone shape that possess unique lipophilic and hydrophilic properties. These unique properties enable cyclodextrins to engulf and bind lipophilic molecules while maintaining aqueous solubility. Encapsulation of molecules is the principal action of a new drug class, selective relaxant binding agents, which binds and inactivate aminosteroid nondepolarizing muscle relaxants. Sugammadex is the name of a modified cyclodextrin currently in phase 3 studies by Organon International (Oss, The Netherlands), and it may hold promise for a new concept in muscle relaxant reversal. Encapsulation rather than competitive antagonism of neuromuscular blockade may be a future modality of anesthetic practice.|Androstanols/antagonists & inhibitors[MESH]|Anesthesia/methods/trends[MESH]|Animals[MESH]|Binding, Competitive[MESH]|Cats[MESH]|Chemistry, Pharmaceutical[MESH]|Clinical Trials as Topic[MESH]|Drug Carriers[MESH]|Drug Evaluation[MESH]|Forecasting[MESH]|Guinea Pigs[MESH]|Haplorhini[MESH]|Humans[MESH]|Metabolic Clearance Rate[MESH]|Mice[MESH]|Neuromuscular Nondepolarizing Agents/antagonists & inhibitors[MESH]|Rocuronium[MESH]|Solubility[MESH]|Sugammadex[MESH]|gamma-Cyclodextrins/*chemistry/pharmacology/*therapeutic use[MESH] |